Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
AnaSpec Releases 4 New Phosphospecific Anti-Tau Antibodies
December 12th, 2008
AnaSpec is excited to announce the release of 4 more new phosphospecific anti-Tau antibodies. This represents the industry's largest collection of anti-Tau antibodies - 17 phosphospecific and 9 non-phosphospecific antibodies. AnaSpec's expertise in phosphopeptide synthesis combined with excellent affinity purification has resulted in the production of an anti-Tau to phosphoserine at position 235 (cat# 55315) clearly delineated from one at phosphoserine position 238 (cat# 55323). AnaSpec's phosphospecific antibodies do not cross-react with each other. Tau is a collection of microtubule-associated proteins that is involved in microtubule assembly...
Source: Health Business Week (2008-12-12)
|
